With advancements in technology, researchers say people with diabetes can easily access health data and plan for the ...
Valued at a market cap of $29.6 billion, San Diego, California-based DexCom, Inc. (DXCM) is a medical device company ...
On Friday, DexCom Inc (DXCM) stock saw a modest uptick, ending the day at $75.88 which represents a slight increase of $1.20 or 1.61% from the prior close of $74.68. The stock opened at $75.51 and ...
This week Bobbi Conner talks with MUSC's Dr. Aundrea Loftley about using a continuous glucose monitor for diabetes management ...
CGMs are prescribed to diabetics to monitor their blood sugar. They're now available and becoming wildly popular for over-the ...
Waiting on Apple to add glucose tracking on a smartwatch to learn about your blood sugar? Don't. Try a biosensor instead.
In recent years, smartwatches and smart rings have grown increasingly popular, adorning the wrists and fingers of consumers who use them to monitor their exercise, sleep and heart ...
24 analysts are following DexCom and have set target prices ranging from $75.0 to $120.0 per share. On average, they have ...
We recently published a list of 12 High Growth Large Cap Stocks to Buy Now. In this article, we are going to take a look at ...
Dexcom has rounded up its celebrity spokespeople for World Diabetes Day, putting singer Nick Jonas at the center of a ...
On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.
This World Diabetes Day, DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing technology, is encouraging ...